Skip to Content

Arrayit Corp ARYC

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Arrayit Corp is a developer, manufacturer, and marketer of next-generation life science tools and integrated systems for the large-scale analysis of genetic variation, biological function, and diagnostics. Using its proprietary and patented technologies, it provides a comprehensive line of products and services that currently serve the sequencing, genotyping, and protein analysis markets. In addition, it also provides tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies and biotechnology companies. Its products include microarrayers, buffers, microarray instruments, printing, substrate slides, software and others. The operations of the firm are carried out through the region of US.

Contact
927 Thompson Place
Sunnyvale, CA, 94085
T +1 408 744-1331
Sector Healthcare
Industry Diagnostics & Research
Most Recent Earnings Sep 30, 2015
Fiscal Year End Dec 31, 2015
Stock Type Speculative Growth
Employees 7